These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 31075230)

  • 1. Role of identified RNA N6-methyladenosine methylation in liver.
    Xu K; Sun Y; Sheng B; Zheng Y; Wu X; Xu K
    Anal Biochem; 2019 Aug; 578():45-50. PubMed ID: 31075230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA.
    Liu N; Parisien M; Dai Q; Zheng G; He C; Pan T
    RNA; 2013 Dec; 19(12):1848-56. PubMed ID: 24141618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.
    Yue Y; Liu J; He C
    Genes Dev; 2015 Jul; 29(13):1343-55. PubMed ID: 26159994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory roles of N6-methyladenosine (m
    Khan FA; Nsengimana B; Awan UA; Ji XY; Ji S; Dong J
    Cancer Gene Ther; 2024 Oct; 31(10):1439-1453. PubMed ID: 38839892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyl-adenosine modification in messenger and long non-coding RNA.
    Pan T
    Trends Biochem Sci; 2013 Apr; 38(4):204-9. PubMed ID: 23337769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
    Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
    Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.
    Zhao Z; Meng J; Su R; Zhang J; Chen J; Ma X; Xia Q
    J Hepatol; 2020 Sep; 73(3):664-679. PubMed ID: 32330603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
    Maity A; Das B
    FEBS J; 2016 May; 283(9):1607-30. PubMed ID: 26645578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system.
    Sweaad WK; Stefanizzi FM; Chamorro-Jorganes A; Devaux Y; Emanueli C;
    J Mol Cell Cardiol; 2021 Nov; 160():56-70. PubMed ID: 33991529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of adipose tissue expansion and adipogenesis by N
    Wu R; Wang X
    Obes Rev; 2021 Feb; 22(2):e13124. PubMed ID: 32935469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
    Liang Z; Kidwell RL; Deng H; Xie Q
    Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    He PC; He C
    EMBO J; 2021 Feb; 40(3):e105977. PubMed ID: 33470439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of m
    Chen XY; Zhang J; Zhu JS
    Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA
    Li Y; Wang J; Huang C; Shen M; Zhan H; Xu K
    Cell Biosci; 2020; 10():19. PubMed ID: 32110378
    [No Abstract]   [Full Text] [Related]  

  • 17. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential.
    Yang D; Qiao J; Wang G; Lan Y; Li G; Guo X; Xi J; Ye D; Zhu S; Chen W; Jia W; Leng Y; Wan X; Kang J
    Nucleic Acids Res; 2018 May; 46(8):3906-3920. PubMed ID: 29529255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic N6-methyladenosine RNA methylation in brain and diseases.
    Shafik AM; Allen EG; Jin P
    Epigenomics; 2020 Feb; 12(4):371-380. PubMed ID: 32081027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-Methyladenosine Methylation of mRNA in Cell Apoptosis.
    Zhang L; Xia J
    Mol Neurobiol; 2024 Jul; 61(7):3934-3948. PubMed ID: 38040996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.